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AbstrAct
background International and domestic funding for 
malaria is critically important to achieve the Sustainable 
Development Goals. Its equitable distribution is key in 
ensuring that the available, scarce, resources are deployed 
efficiently for improved progress and a sustained response 
that enables eradication.
Methods We used concentration curves and 
concentration indices to assess inequalities in malaria 
funding by different donors across countries, measuring 
both horizontal and vertical equity. Horizontal equity 
assesses whether funding is distributed in proportion to 
health needs, whereas vertical equity examines whether 
unequal economic needs are addressed by appropriately 
unequal funding. We computed the Health Inequity Index 
and the Kakwani Index to assess the former and the latter, 
respectively. We used data from the World Bank, Global 
Fund, Unicef, President’s Malaria Initiative and the Malaria 
Atlas Project to assess the distribution of funding against 
need for 94 countries. National gross domestic product 
per capita was used as a proxy for economic need and 
‘population-at-risk’ for health need.
Findings The level and direction of inequity varies across 
funding sources. Unicef and the President’s Malaria Initiative 
were the most horizontally inequitable (pro-poor). Inequity 
as shown by the Health Inequity Index for Unicef decreased 
from −0.40 (P<0.05) in 2006 to −0.25 (P<0.10) in 2008, and 
increased again to −0.58 (P<0.01) in 2009. For President’s 
Malaria Initiative, it increased from −0.19 (P>0.10) in 2006 
to −0.38 (P<0.05) in 2008, and decreased to −0.36 (P<0.10) 
in 2010. Domestic funding was inequitable (pro-rich) with 
inequity increasing from 0.28 (P<0.01) in 2006 to 0.39 
(P<0.01) in 2009, and then decreasing to 0.22 (P<0.10) in 
2010. Funding from the World Bank and the Global Fund 
was distributed proportionally according to need. In terms of 
vertical inequity, all sources were progressive: Unicef and the 
President’s Malaria Initiative were the most progressive with 
the Kakwani Indices ranging from −0.97 (P<0.01) to −1.29 
(P<0.01), and −0.90 (P<0.01) to −1.10 (P<0.01), respectively.
conclusion Our results suggest that external funding of 
malaria treatment tends to be allocated to countries with 
higher health and economic need but not in proportion 
to their relative health need and income when compared 
to other countries. While malaria eradication might 
require funders to disproportionally allocate funding that 
goes beyond (financial and health) need, our analysis 
highlights that funders might potentially be targeting in 
excess certain countries. Regular assessments of need 
and greater coordination among donors are necessary 
for equitable resource allocation, to improve and sustain 
progress with malaria control and elimination.
IntroductIon
Controlling malaria is a global health priority,1 
and a target for the Sustainable Development 
Goal 3 (SDG3) to eliminate malaria by 2030. 
Despite a reduction in malaria case incidence 
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Key questions
What is already known about this topic?
 ► Previous studies hint at inequitable distribution of 
malaria funding across countries.
 ► However, nothing is known about the level of 
inequality and of (horizontal and vertical) inequity in 
malaria funding.
What are the new findings?
 ► Inequity of funding in relation to both health and 
economic need varies with the source of malaria 
funding in 2006–2010.
 ► External funding from Unicef and President’s 
Malaria Initiative was the most horizontally 
inequitable (pro-poor), while domestic funding 
was inequitable (pro-rich) in all years. In terms of 
vertical equity, all external sources of funding were 
progressive: Unicef and President’s Malaria Initiative 
were the most progressive.
recommendations for policy
 ► Regular assessments of need and greater 
coordination among donors are necessary 
for equitable resource allocation, to improve 
and sustain progress with malaria control and 
elimination.
 ► Therefore, measuring both vertical and horizontal 
equity can inform how global malaria funding can 
be efficiently allocated.
 ► These are crucial in the context of the funding 
shortfall of $5.1 billion each year to combat malaria, 
as estimated by the World Health Organization.
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of 41% and mortality of 62% since 2000, an estimated 
2.8 billion people globally are still at risk of malaria and 
1.1 billion are at high risk of developing the disease.2 
In low- and middle-income countries (LMICs) where 
malaria is endemic, SDG3 are unlikely to be achieved, 
with malaria imposing substantial health and economic 
burden on the societies it affects—each year Africa 
loses around £8 billion due to malaria.3 4 In addition to 
the mortality and morbidity it causes in adults and chil-
dren, malaria adversely affects educational attainment of 
children, and consequently, reduces their life chances.5 
Countries affected by malaria experience major barriers 
to achieving the demographic dividend—so critical for 
sustainable development.6 
Most of the affected countries are under-resourced to 
effectively fight malaria and need sustained international 
funding.7 International funding plays a critical role in 
alleviating the burden of malaria and has significantly 
increased8 from $149 million in 2000 to $1.2 billion in 
2008 and to $2.3 billion in 2011.3 9 In 2013, however, while 
worldwide funding for malaria control and elimination 
had increased to $2.7 billion, international investment 
declined to $2.18 billion.10 The funding in 2013 was well 
short of the $5.1 billion needed each year, as estimated 
by the World Health Organization (WHO).10 Since 2008, 
the economic crisis and austerity measures imposed by 
donor countries have resulted in stagnation and decline 
in international funding.8 Hence, there is an imperative 
to deploy available resources efficiently and equitably 
to ensure sustainability of the malaria response8 and to 
ensure funding shortfall does not lead to the upsurge of 
malaria.3
While the adequacy of funding is critical, its equitable 
distribution is equally important to ensure resources are 
efficiently allocated to those that need them the most. 
Both vertical equity (unequal treatment of unequals in 
a fair sense) and horizontal equity (equal treatment for 
equal need) are important when analysing the adequacy 
of malaria funding. Equity analysis allows assessing 
whether funding is distributed according to health need 
and country affordability of malaria treatment. Yet, few 
studies have explored (beyond descriptive analysis) 
equity of funding for malaria globally.
Snow et al.7 assessed the adequacy of malaria funding 
and find that, while international funding for malaria 
increased substantially since 2007, African countries were 
the major recipients of international assistance and coun-
tries where Plasmodium vivax continues to pose a threat 
did not receive enough funding. Assistance was found 
to be inadequate for 50 countries, and donor funding 
did not correlate with economic status of the country. 
Similarly, Pigott et al.8 concluded that few countries with 
large populations at risk receive adequate funding. The 
observed existence of inadequacy presents concerns with 
respect to the achievement of global malaria targets. 
While both studies are important contributions towards 
understanding the nature of international funding and 
drawing attention to inequalities in funding based on 
both biological and economic need, they do not measure 
inequity in malaria funding. In this paper, we build on 
the extant studies by measuring both horizontal and 
vertical equity in malaria funding. We compare inequity 
at cross-country level in domestic (Government) funding 
(GovStats in figures/tables) and across the major inter-
national sources of malaria funding, namely the Presi-
dent’s Malaria Initiative (PMI), the World Bank, Unicef 
and the Global Fund to Fight AIDS, Tuberculosis and 
Malaria (Gfatm in figures/tables).
MetHods And dAtA
data
The dataset used covered 94 countries across different 
world regions (Americas, Asia and Africa) from 2006 to 
2010. Data on funding were obtained from both inter-
national donors and government funds. Data for gross 
domestic product (GDP) per capita are from the World 
Bank data. Absolute values for health indicators as 
proxied by stable and total population at risk were calcu-
lated as outlined in Pigott et al.8
Data on external funding by country were obtained 
from several sources—the PMI data were taken from 
the fifth annual report up to financial year 2010 and the 
Malaria Operational Plans for year 2011.11 The Global 
Fund data were based on the organisation’s Country 
Portfoliosi,12Unicef data were obtained from the Creditor 
Reporting System from the Organization for Economic 
Co-operation and Development (OECD) statistics13 and 
the World Bank figures were taken from the Booster 
Program grants listing.14 We used data on ‘disburse-
ments’ instead of ‘commitments’ since the former pres-
ents a more accurate picture of the actual funding made 
available to countries. We had data available on disburse-
ments from the Global Fund12 and PMI11 up to 2009, and 
from the World Bank and Unicef for the period between 
2006 and 2008.13
Data for domestic funding were obtained from grant 
proposals to the Global Fund since such reports are 
considered valid and unbiased, and allow us avoiding 
double counting as they provide a detailed account of 
malaria budgets. Data for countries that did not request 
Global Fund support were obtained from the World 
Malaria Report 2011.15 The figures for domestic funding 
and external disbursements were added to obtain total 
funding received (henceforth TotalReceived).
Data for GDP from 2006 to 2010 were taken from the 
World Bank Development Indicators Data.16 The data 
are expressed in per capita constant US$ adjusted for 
purchasing power  parity.ii 
i Country portfolios refer to the different areas that the Global Fund 
invests in each country. For example, the investments made into HIV, 
tuberculosis and malaria. The portfolio here is the collection of funds 
received by each country devoted to malaria eradication and prevention.
ii It could be argued that GDP per capita is an imperfect measure of 
"financing need" as income per capita might not be a good proxy for 
how poor a country is if income distribution is skewed within a country. 
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We used total ‘population-at-risk’  of malaria transmission 
as a proxy for health need. As outlined in Pigott et al.,8 we 
used figures for populations at risk of stable transmission 
(StablePAR) and total (including stable and unstable) 
transmission (TotalPAR) of Plasmodium (P.) falciparum and 
Plasmodium vivax. These were calculated using the popu-
lation at risk of transmission for both P. falciparum and 
P vivax in 2010, described in detail in Pigott et al.8 and 
produced by Malaria Atlas Project (MAP).17 18
The definition of health need imposes challenges, as 
thoroughly discussed in the literature,19–21 and ultimately 
rests on value judgements.22 It would be desirable to have 
measures of population health needs evaluated through 
health losses attributable to malaria and its associated 
risks. Previous literature has used different measures 
such as the proportion of people affected at a given point 
in time, proportion of population by endemicity, adult 
and child malaria deaths, and WHO estimates of ‘popula-
tion-at-risk’.9 However, these data are either low resolution 
(at a crude geographic level), based on inaccurate case 
reports, or have large uncertainty. We used data on ‘popu-
lation-at-risk’  of malaria, readily available for 94 coun-
tries from MAP.8 23 The MAP data are based on a hugely 
expanded evidence-base, are of high resolution and are 
comparatively less uncertain.8 23
Methods
Inequalities were measured through concentration 
curves (CCs) and concentration indices (CIs).24 While 
these analyses are useful to assess how funding is distrib-
uted across countries, inequalities observed through the 
concentration curves and indices must not be directly 
interpreted as inequity. Variation in disbursements due 
to differences in healthcare need or affordability might 
be a legitimate source of inequality. Those countries with 
greater burden of disease legitimately ought to be enti-
tled to higher disbursements compared with those with 
lower disease burden. Therefore, to determine the extent 
of inequity a comparison needs to be made between the 
distributions of need (malaria burden) with the distribu-
tion of malaria funding across income deciles: we refer to 
this concept as horizontal inequity.
The concentration curves in this context plot the cumu-
lative proportion of countries ranked by living standards 
(proxied by GDP per capita) against the cumulative propor-
tion of need (proxied by TotalPAR and StablePAR) and 
expenditure in malaria (proxied by per capita funding). 
Additionally, it might also not be indicative of how much a country 
spends on healthcare. However, GDP per capita is widely used as a 
proxy for income in country-level analysis as it is readily available and 
has been found to correlate with other proxies of income distribution 
within countries as well as with healthcare expenditure. While these 
are legitimate concerns, we believe that these are not strong limitations 
in our analysis since we are looking at distributions across countries. 
Therefore, while it can be argued that GDP per capita can be an imper-
fect proxy of "financing need", at most we are incurring a measurement 
error rather than a systematic bias. Our analysis would only be distorted 
systematically if inequality within countries would correlate with the 
ranking of countries according to GDP per capita.
The extent of horizontal inequity is assessed by measuring 
the Health Inequity Index (HII) that is computed as the 
difference between the concentration index for healthcare 
expenditure (used as a proxy for healthcare; in our case 
malaria funding) and that for health need.24 25
It can also be argued that countries with lower domestic 
affordability for treatment legitimately ought to be enti-
tled to higher disbursements compared with richer 
countries. Therefore, to determine the extent of vertical 
inequity we compared the concentration curve for GDP 
per capita (Lorenz curve) with the concentration curve 
of malaria funding across income deciles. Vertical ineq-
uity was then measured through the Kakwani Index (KI), 
which is the most widely used measure of progressivity in 
financing of a health system.20 25 26 The KI allows assessing 
the extent to which countries with unequal ability to 
finance malaria control and elimination receive appro-
priately unequal funding from international donors. 
More specifically, the concept of vertical equity helps to 
identify whether a particular funding source is ‘progres-
sive’ (i.e. pro-poor), regressive (i.e. pro-rich) or propor-
tional (i.e. aligned to economic status).iii Further details 
on these methods can be found in the online supplemen-
tary material appendix.
results
Online supplementary figure A1 shows the total funding 
disbursed by source of funding from 2006 to 2010. The 
Global Fund has consistently been one of the highest 
donors, especially in 2009 and 2010. The lowest funds 
disbursed were by Unicef across all years. Domestic 
funding was the highest source of funding in 2006, 
2007 and 2008. Online supplementary table A1 presents 
descriptive statistics in detail.
Online supplementary figures B1–B6 show the 
average funding for each source (overall and by year), 
with countries grouped by income quintiles (1=lowest 
to 5=highest). Overall the data suggest that countries 
in the lowest income quintile (first quintile) receive 
substantially higher disbursements compared with those 
in higher quintiles  (online supplementary figure B1) . 
However, countries in the second lowest quintile receive 
slightly lower disbursements than countries in the third 
quintile. Moreover, while total funding seems to be 
progressive (decreases as income quintile increases) in 
2006 and 2010, the picture is mixed for the other years.
To consider health need, and therefore make more 
definitive conclusions regarding inequality in funding, we 
rely on the concentration curves and indices presented 
in the next section.
iii It could be argued that given there is a close relationship between 
disease burden and GDP, the vertical and horizontal equity analysis 
tell conceptually the same construct. However, while GDP and disease 
burden are correlated, these are not perfectly correlated (-0.19 (P<0.01) 
for TotalPAR and -0.06 (P>0.10) for StablePAR), and therefore the two 
analyses capture different inequality and inequity constructs.
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Figure 1 Concentration Index by funding source.
Inequality, concentration curves and Indices
Online supplementary figures A2–A6 show CCs for each 
source of funding per year of the analysis. For example, 
in terms of the distribution of health need (i.e. malaria 
burden), the CCs for both StablePAR and TotalPAR 
are above the equality line throughout the distribu-
tion (online supplementary figure A2), suggesting that 
poorer countries exhibit higher proportions of affected 
populations than richer countries. For example, in 
2006, the curve for TotalPAR shows that approximately 
50% of the malaria burden was attributed to the 40% 
poorest countries. Similarly, 75% of the malaria burden 
was concentrated in the 60% poorest countries. This 
pattern is verified across all years (online supplemen-
tary figures A3–A6), and the share of malaria burden 
remains relatively stable across all years. This is 
confirmed by the statistically significant CIs (P<0.01 for 
all years; online supplementary table A2) that are nega-
tive throughout without large differences in magnitude 
from one year to another.
In what follows, we discuss inequality in funding 
by assessing the distribution of funding from each 
source. Online supplementary figures A2–A6 illus-
trate concentration curves for the different sources of 
funding and the Lorenz curve for the years 2006–2010.
In all years, the Lorenz curve lies below the equality 
line, highlighting high inequality (pro-rich) in the income 
distribution across countries for all years (e.g., 60% of the 
poorest have only around 20% of the global income in all 
years). Similarly, domestic funding is below the equality 
line in all years, indicating pro-rich inequality (except in 
2010 where it crosses the equality line at several points 
of the distribution). All the other sources of funding are 
above the equality line, indicating pro-poor inequality in 
malaria funding with the exception of the World Bank, 
which is below the equality line in the first quartile of 
the distribution in 2007 and 2010. Similarly, TotalRe-
ceived funding crosses the equality line and lies below it 
in the very last part of the distribution for 2006, 2007 and 
2008. Overall, one can infer from the curves that PMI 
and Unicef exhibit the highest level of pro-poor inequality 
along with both sources showing their CCs farthest from 
the equality line in 2009. In fact, all sources of funding, 
except for the World Bank, show the largest inequalities 
in this year. The World Bank shows pro-poor inequality; 
however, on careful observation it can be seen that for 
most years its CCs are very close to the equality line in 
the first one-third of the distribution, and then moves 
further away. Together, these findings suggest that for 
the subgroup of countries at the bottom of the income 
distribution funding tends to be distributed according to 
income, while for the upper part of the income distribu-
tion the distribution of funding is pro-poor.
These results are confirmed by the CIs (online supple-
mentary table A2 and figure 1iv). For World Bank (P<0.05 
for years 2006 and 2008, and P<0.10 for the rest), Unicef 
(P<0.01 for all years) and PMI (P<0.01 for all years 
except 2006 when P<0.05), the indices are always nega-
tive, implying that these funding sources exhibit pro-poor 
(countries) inequality. In terms of magnitude of the 
inequality, the indices confirm the concentration curves 
analysis. Across most years, Unicef and PMI exhibit more 
pro-poor inequality. The CIs for domestic funding are 
positive (P<0.05 for 2009), indicating pro-rich inequality 
for this source of funding. However, it is not statisti-
cally significant in other years. For the Global Fund, the 
CIs are negative in all years, suggesting that this source of 
funding is pro-poor unequal in these years, but is statisti-
cally significant only in 2010 (P<0.01).
While it is interesting to understand the degree of 
pro-rich or pro-poor inequality per funding source, equally 
interesting is to know whether the concentration indices 
are significantly different between donors, that is, 
whether one funding source is significantly more unequal 
compared with another donor in a particular year. We 
use dominance testing, a standard method in this type of 
analysis to compare significant differences between two 
concentration curves. We explain the method in detail in 
the supplementary material. Online supplementary tables 
A3a–A3e and A4a–A4f show the results of the dominance 
testing. Overall, we see that Unicef dominates over most 
funding sources in all years, indicating that it is signifi-
cantly more pro-poor unequal than most other sources of 
funding (online supplementary tables A3a-A3e). We do 
not find any significant within-donor differences in the 
index (online supplementary tables A4a-A4f).
Health Inequity Index
The HII results are presented in the online supplemen-
tary table A5, and its evolution over time in figure 2. 
iv  Figure 1 shows the inequality trend for each source of funding from 
2006 to 2010. The horizontal line (0) represents the line of equality. Note 
that in the concentration curve figures (online supplementary figures 
A2– A6), a curve above (below) the equality line means a negative (posi-
tive) concentration index and thus pro-poor (pro-rich) inequality. In 
figure 1, however, we directly present the concentration index, hence 
a negative concentration index equivalently means pro-poor inequality 
but will lie below the equality line (0) and vice versa.
 o
n
 15 O
ctober 2018 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2017-000496 on 28 December 2017. Downloaded from 
Barrenho E, et al. BMJ Glob Health 2017;2:e000496. doi:10.1136/bmjgh-2017-000496 5
BMJ Global Health
Figure 2 Health Inequity Index by funding source.
Figure 3 Kakwani Index by funding source.
Unicef and PMI are the most horizontally inequitable 
(pro-poor) sources of funding as shown by the negative 
index. Unicef is the most inequitable (pro-poor) with statis-
tically significant indices in all years (P<0.05 for 2006, 
2007 and 2010; P<0.10 for 2008 and P<0.01 for 2009). 
PMI is statistically significantly negative (i.e. inequitable 
pro-poor) in all years (P<0.05), except in the year 2006 
when it is not significant. Domestic funding is positive 
and statistically significant in all years, suggesting hori-
zontal inequity pro-rich (P<0.01 in all years except 2010 
when P<0.10).
robustness check
As a robustness check, we have also estimated the CIs 
and the HII using funding divided by total ‘popula-
tion-at-risk’  (TotalPAR) instead of funding per capita. 
The online supplementary tables A6-A7 present these 
results with the CIs and P-values. For the CIs, the results 
remain qualitatively the same with the exception of the 
CI for domestic funding that is now significant (P<0.01 
in all years) and for total funding received which is now 
significantly pro-rich in all years. With respect to the HII, 
the results are qualitatively the same as before.
Progressivity and the Kakwani Index
Across all years (2006–2010), the Lorenz curve envelopes 
and lies below the concentration curves for all sources 
of funding (see online supplementary figures A2–A6), 
suggesting that all sources of funding tend to be progres-
sive in nature. The KIs  and the corresponding 95% confi-
dence intervals and P-values in the online supplementary 
table A8 confirm these results. Overall, it can be seen that 
for all sources of funding the index is negative and signif-
icant (P<0.01), indicating progressivity in funding. If one 
compares the magnitude of the KIs, the results suggest 
that Unicef and PMI are the most progressive sources of 
funding, while domestic funding is the least progressive 
source of funding in all the years. Figure 3 shows the KIs 
as a time trend graph.
dIscussIon
Despite substantial increases in international donor assis-
tance to control and eliminate malaria since 2000, inter-
national and domestic funding falls short of the required 
level estimated by the WHO.7 The SDG3 are unlikely to 
be achieved without effective control and elimination 
of malaria, given the substantial health and economic 
burden it imposes on the affected societies.
Since the global economic crisis of 2008, adequacy of 
funding for malaria control and elimination has received 
substantial attention due to declined funding. Equity in 
funding, although explored in some earlier studies,6 7 
has, however, received comparatively less attention.
In times of economic uncertainty and austerity, funding 
must be targeted at the most vulnerable groups in terms 
of both health risk and economic need7 to ensure scarce 
resources reach where they should. Such strategic deci-
sions ought to be informed by a routine assessment of 
vertical and horizontal equity of funding distribution.
This study is the first to analyse equity of malaria 
financing from different funding sources, with respect to 
health need and economic need. The study uses, for the 
first time, HII and KI to quantify the degree of inequity 
in malaria funding in total and by source of funding at a 
cross-country level.
We find that while inequity in funding in relation to 
both health and income exists, some external funding 
sources are more inequitable than others. For example, 
for both horizontal and vertical equity, Unicef and PMI 
are the most inequitable (pro-poor) sources of funding. 
The HII (measuring horizontal inequity) for Unicef 
decreased from −0.40 (P<0.05) in 2006 to −0.25 (P<0.05) 
in 2008, and increased again to −0.58 (P<0.01) in 2009. 
For PMI, the HII increased from −0.19 (P>0.10) in 2006 to 
−0.38 (P<0.05) in 2008, and decreased to −0.36 (P<0.10) 
in 2010. Unicef and PMI were the most progressive with 
KIs ranging from −0.97 (P<0.01) to − 1.29 (P<0.10), and 
−0.90 (P<0.01) to −1.10 (P<0.01), respectively. The World 
Bank and the Global Fund, however, show funding to be 
proportionally distributed according to need. Similarly, 
total funding received is also proportionally distributed.
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The assessment of domestic funding indicates it is a 
progressive funding source and horizontally inequitable 
but in favour of the richer countries (i.e. pro-rich), with 
inequity increasing from 0.28 (P<0.01) in 2006 to 0.39 
(P<0.01) in 2009, and then decreasing to 0.22 (P<0.10) 
in 2010. This finding is not surprising given that richer 
countries can afford greater levels of funds for their own 
malaria programme compared with poorer countries. 
High-income countries simply have more fiscal space for 
expenditure on health in general, and this reflects such 
overall trends in government health expenditure. This 
finding, however, highlights the need for international 
funding to be distributed more strategically in order 
to counterbalance the lack of affordability in poorer 
countries.
Overall, our results suggest that while external funding 
of malaria treatment tends to be allocated to countries 
with higher health and economic need it is not allocated 
in proportion to countries’ relative need.
The normative assessment on the adequacy of dispro-
portionally favouring higher (health and financial) need 
countries would require consensus on a global welfare 
function and preferences against which distribution of 
funding could be assessed.
However, if such global preferences are aligned with 
funding being distributed in proportion to relative need, 
our results suggest that there should be better coordi-
nation between funders. Indeed, the existing donor 
allocation mechanisms do not involve international coor-
dination across funders. Instead, funders individually 
negotiate with each country, leading to disproportionate 
allocation of funding that does not reflect relative need 
across countries.
Coordination across funders, combined with a shared 
vision of what global preferences ought to be, can 
potentiate resource allocation mechanisms that enable 
equitable use of global funding across countries. Such 
allocation mechanisms ought to involve a thorough 
assessment of global health needs, how these are distrib-
uted across different countries, the progressivity of the 
different funding sources and how countries compare 
in terms of their domestic financial ability to address 
current and future needs. Amid the widely recognised 
important principles of equity underpinning resource 
allocation, its usage is still almost entirely confined to the 
allocation of resources within higher-income countries, 
with few LMICs, as well as international donors, using 
equity as a criterion for resource allocation.27 28
Our study has three limitations that might affect 
the results and their interpretation. First, the analysis 
assumes that StablePAR and TotalPAR are legitimate 
sources of variation in funding. To the extent that these 
capture need accurately and fully, the interpretation of 
the inequality and inequity holds. Further, these indica-
tors represent ‘population-at-risk’  and, therefore, might 
overestimate the number of people affected by malaria 
and, hence, malaria burden. Second, the data used are 
at the country level and, hence, we are unable to assess 
how funding is distributed internally across the different 
subgroups of each national population. As a result, we 
are unable to assess inequalities within country due to 
income, need and other socioeconomic determinants, all 
of which are instrumental in the impact of the disburse-
ments. We use GDP per capita at the country level to rank 
countries, which might mask inequalities in income distri-
bution within countries. Given that the malaria burden 
might be strongly correlated with income, we might be 
underestimating inequality in funding.
Third, ideally, we would include more recent informa-
tion in our analysis. However, we have not been successful 
in gathering complete data on all variables we need for 
a broader range of years. In particular, data on the ‘popu-
lation-at-risk’  that we use in this paper from the Malaria 
Atlas Project are available largely only for African coun-
tries after 2010.
The World Malaria Report 20162 reports decreasing 
trends from 2011 to 2015 in total funding. While the 
extrapolation of our results into more recent years would 
require better data on the distribution of funding and 
need across countries, our results highlight that, in the 
context of reduced funding, the equitable distribution of 
the available funding becomes all the more important. 
Further research would also help in illuminating 
important policy questions. First, with data that are more 
refined further research can decompose the inequity 
in malaria funding to identify its legitimate and illegiti-
mate sources, and assess the role of each of these sources 
in explaining and addressing the burden of malaria. 
Second, it would also be important to assess the strategies 
and processes behind external donor decision-making 
concerning funding allocation in order to identify the 
barriers and enablers towards improving equity in malaria 
funding. Third, even if malaria funding were equitably 
distributed across countries, it would be important to 
assess how equitable the distribution of that funding is 
within each country. That analysis requires detailed with-
in-country individual data on socioeconomic characteris-
tics (such as income, education, health, among others) 
along with detailed data on deployment of funding 
within a country and across its population.
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